Durvalumab versus Physician's Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): A Multicenter, Randomized, Phase 2 Trial
Durvalumab 与医生选择的化疗方案治疗复发性卵巢透明细胞腺癌 (MOCCA/APGOT-OV2/GCGS-OV3):一项多中心、随机、II 期试验
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-25-0201
Ngoi, Natalie Y L; Choi, Chel Hun; Zhu, Junxian; Lim, Diana; Tan, Tuan Zea; Sun, Haoyang; Heong, Valerie; Ow, Samuel G W; Chay, Wen Yee; Kim, Hee Seung; Lim, Yi Wan; Lim, Siew Eng; Goss, Geraldine; Goh, Jeffrey C; Kim, Jae-Weon; Friedlander, Michael; Tai, Bee Choo; Kim, Kidong; Tan, David S P